SCHEMBL297200

SCHEMBL297200

C=CC[O+](CC=C)CC=C

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL158759 0.86
SCHEMBL3665251 0.80
SCHEMBL1101397 0.60
SCHEMBL31512657 0.60
SCHEMBL36456 0.60
SCHEMBL6680699 0.57
SCHEMBL1060118 0.57
Ammonia Solution, Strong SCHEMBL9647 0.57
Phosphine SCHEMBL15013438 0.57
SCHEMBL3421119 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 656 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240158564-A1 QUATERNARY AMMONIUM-FUNCTIONALIZED POLYMERS AND METHODS OF MAKING AND USING SAME U.S. DEPARTMENT OF ENERGY 2024-05-16 US claimed
EP-4130011-A2 COMPOUNDS BASED ON AN ELEMENT OF THE BORON FAMILY AND USE THEREOF IN ELECTROLYTE COMPOSITIONS SCE France (FR) 2023-02-08 EP claimed
EP-3559008-B1 COMPOUNDS BASED ON A BORON-GROUP ELEMENT AND THEIR USE IN ELECTROLYTE COMPOSITIONS SCE FRANCE (FR) 2022-11-02 EP claimed
US-11345657-B2 Sulfamic acid derivatives and processes for their preparation HYDRO-QUEBEC (CA) 2022-05-31 US claimed
US-11228057-B2 Compounds based on an element from the boron group, and use thereof in electrolyte compositions SCE FRANCE (FR) 2022-01-18 US claimed
US-20200181071-A1 SULFAMIC ACID DERIVATIVES AND PROCESSES FOR THEIR PREPARATION HYDRO-QUéBEC (CA) 2020-06-11 US claimed
EP-3559008-A1 COMPOUNDS BASED ON AN ELEMENT FROM THE BORON GROUP, AND USE THEREOF IN ELECTROLYTE COMPOSITIONS SCE France (FR) 2019-10-30 EP claimed
EP-3529232-A1 SULPHAMIC ACID DERIVATIVES AND PRODUCTION METHODS THEREOF Hydro-Québec (CA) 2019-08-28 EP claimed
WO-2018115793-A1 COMPOUNDS BASED ON AN ELEMENT FROM THE BORON GROUP, AND USE THEREOF IN ELECTROLYTE COMPOSITIONS SCE FRANCE (FR) 2018-06-28 WO claimed
WO-2018072024-A1 SULPHAMIC ACID DERIVATIVES AND PRODUCTION METHODS THEREOF HYDRO-QUéBEC (CA) 2018-04-26 WO claimed
EP-0094014-B1 PROCESS FOR PREPARING COLORLESS HYDROXYL EPIHALOHYDRIN POLYMERS The B.F. GOODRICH Company (US) 1986-06-18 EP claimed
US-RE31468-E POLYEPIHALOHYDRIN ENDCAPPED WITH HYDROXYALKYL ACRYLATE THE B. F. GOODRICH COMPANY (US) 1983-12-20 US claimed
EP-0004172-B1 BENZOCYCLOHEPTAPYRANS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM ELI LILLY AND COMPANY (US) 1982-04-07 EP claimed
EP-0035029-A4 REACTIVE LIQUID POLYMERS. GOODRICH CO B F (US) 1982-01-26 EP claimed
EP-0035029-A1 REACTIVE LIQUID POLYMERS The B.F. GOODRICH Company (US) 1981-09-09 EP claimed
WO-1981000716-A1 REACTIVE LIQUID POLYMERS GOODRICH CO B F (US) 1981-03-19 WO claimed
US-4256904-A AN EPIHALOHYDRIN POLYMER ENDCAPPED WITH ACRYLIC OR METHACRYLIC ACID; TOUGHNESS AFTER CURING THE B. F. GOODRICH COMPANY (US) 1981-03-17 US claimed
US-4256910-A AN EPIHALOHYDRIN POLYMER ENDCAPPED WITH AN HYDROXYALKYL ACRYLATE OR METHACRYLATE; TOUGHNESS AFTER CURING THE B. F. GOODRICH COMPANY (US) 1981-03-17 US claimed
US-4225705-A QUATERNIZATION OF A BENZOTHIAZOLE, CONDENSED WITH A BENZOTHIAZOLIUM BETAINE BADER HENRY 1980-09-30 US claimed
US-4146736-A INSERTION OF OXYALKYLENE GROUPS INTO CHAIN-TYPE ETHERS, LEWIS ACID CATALYSTS HOECHST AKTIENGESELLSCHAFT (DE) 1979-03-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11345657-B2 Sulfamic acid derivatives and processes for their preparation STS, SCLY, MPST TSHR 1516/4885ALDH1A1 485/4885
US-20200181071-A1 SULFAMIC ACID DERIVATIVES AND PROCESSES FOR THEIR PREPARATION STS, SCLY, MPST TSHR 1516/4885ALDH1A1 485/4885
US-20240158564-A1 QUATERNARY AMMONIUM-FUNCTIONALIZED POLYMERS AND METHODS OF MAKING AND USING SAME ALKBH3, ABHD10, ALKBH2 TSHR 3740/4885ALDH1A1 3265/4885
US-11228057-B2 Compounds based on an element from the boron group, and use thereof in electrolyte compositions ALPG, SLC26A3, CA9 TSHR 4198/4885ALDH1A1 2693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.